TAOX
TAO Synergies Inc.
1W: +5.5%
1M: +58.2%
3M: +18.5%
YTD: +34.3%
$5.95
+0.31 (+5.50%)
After Hours: $5.90 (-0.05, -0.84%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$20.7M
52W Range1.84-11.98
Volume343,431
Avg Volume157,640
Beta2.05
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJoshua N. Silverman
Employees4
SectorHealthcare
IndustryBiotechnology
IPO Date2025-07-02
Websitesynaptogen.com
1185 Avenue of the Americas, 3rd Floor
New York 10036
US
New York 10036
US
About TAO Synergies Inc.
Clinical-stage biopharmaceutical company developing a bryostatin‑1 platform for Alzheimer’s and other neurodegenerative/cognitive diseases. Also pivoting to a digital-asset treasury strategy focused on acquiring and staking TAO cryptocurrency.
Latest News
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| WEINSTEIN ROBERT | A-Award | 10,000 | — | 2025-10-17 |
| WEINSTEIN ROBERT | F-InKind | 4,000 | $7.23 | 2025-10-17 |
| Singer William S. | A-Award | 15,000 | — | 2025-10-17 |
| Singer William S. | F-InKind | 6,000 | $7.23 | 2025-10-17 |
| Silverman Joshua | A-Award | 100,000 | — | 2025-10-17 |